Responses
Pancreatic cancer
Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.